Skip to main content
Gregory Grabowski, MD, Medical Genetics, Cincinnati, OH, Cincinnati Children's Hospital Medical Center

GregoryAGrabowskiMD

Medical Genetics • Cincinnati, OH

Clinical Biochemical Genetics, Clinical Genetics, Clinical Molecular Genetics

Professor, Pediatrics, University of Cincinnati College of Medicine

Join to view full profile

Dr. Grabowski is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Grabowski's full profile

Already have an account?

Summary

  • Dr. Grabowski received his M.D. from the University of Minnesota where he also completed his residency in Pediatrics and fellowship training in Human Genetics. He then established his research and clinical programs at the Mount Sinai School of Medicin where he developed the world’s largest clinic for patients afflicted with Gaucher disease and other lysosomal diseases. He established basic research and diagnostic laboratories for genetic diseases as well as the first treatment center for enzyme therapy in Gaucher disease. Following these highly productive 13.5 years, he became the A. Graeme Mitchell Chair of Human Genetics, and Director of Human Genetics (DHG) at the Cincinnati Children’s Hospital Research Foundation. He was Professor of Molecular Genetics and Biochemistry, and Pediatrics, at the University of Cincinnati College of Medicine. In these positions, he formed the clinical, educational, diagnostic, and research infrastructure for the DHG and its ~30 faculty. During his research career, he has published over 320 scholarly works on the basic and clinical sciences of lysosomal storage and genetic diseases, while maintaining active clinical and treatment programs genetic diseases. He has continuously served on committees of the National Institutes of Health, the national and state governments, and many philanthropic (through the Project Hope Gaucher Disease Initiative) and patient foundations. He is a member of the American Society for Clinical Investigation, the American Association of Physicians, the editorial board of Molecular Genetics and Metabolism, and other societies. He has served as President of the Society for Inherited Metabolic Diseases. His continuing passion has been to discover and develop specific treatments for inherited diseases. In 2014, he joined Synageva BioPharma as Chief Scientific Officer. After Alexion acquired Synageva in June 2015, he became Emeritus Professor of Pediatrics and Genetics and consults for several Biotech companies.

Education & Training

  • University of Minnesota Medical School
    University of Minnesota Medical SchoolPost-Doctoral Fellowship, Human/Medical Genetics, 1976 - 1979
  • University of Minnesota
    University of MinnesotaResidency, Pediatrics, 1974 - 1978
  • University of Minnesota Medical School
    University of Minnesota Medical SchoolClass of 1974

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 1992 - 2025
  • SC State Medical License
    SC State Medical License 2011 - 2019
  • MN State Medical License
    MN State Medical License 1978 - 1979
  • American Board of Medical Genetics and Genomics Clinical Biochemical Genetics
  • American Board of Medical Genetics and Genomics Clinical Genetics
  • American Board of Pediatrics Pediatrics

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 1991

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • National Baromedical Services: Primary Training in Hyperbaric Medicine 
    Undersea and Hyperbaric Medical Society, Columbia, South Carolina - 6/17/2013

Press Mentions

  • Rare Genetic Disorder Provides Unique Insight into Parkinson’s Disease
    Rare Genetic Disorder Provides Unique Insight into Parkinson’s DiseaseJune 23rd, 2011
  • University of Utah Health Program General Surgery Residency
    University of Utah Health Program General Surgery ResidencyJanuary 13th, 2021

Grant Support

  • Epidemiology And Natural History Of Wolman And Cholesteryl Ester Stor (GRABOWSKI)National Institute Of Neurological Disorders And Stroke2010–2011
  • Studies Of Gaucher Disease: A Prototype LipidosisNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2011
  • Therapy Of Gaucher Disease: In Vivo Enhancement Of Residual Mutant ActivityNational Institute Of Neurological Disorders And Stroke2010
  • Therapy Of Neuronopathic Gaucher DiseaseEunice Kennedy Shriver National Institute Of Child Health &Human Development2010
  • Therapy Of Gaucher Disease: In Vivo Enhancement Of Residual Mutant ActivityNational Institute Of Neurological Disorders And Stroke2009
  • GrabowskiNational Institute Of Neurological Disorders And Stroke2009
  • Therapy Of Neuronopathic Gaucher DiseaseEunice Kennedy Shriver National Institute Of Child Health &Human Development2009
  • Studies Of Gaucher Disease: A Prototype LipidosisNational Institute Of Diabetes And Digestive And Kidney Diseases1993–2009
  • Use Of Hammerhead Ribozymes In Murine Models Of OlNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2006–2007
  • Gaucher Disease StudyNational Center For Research Resources2004–2007
  • Studies Of Prosaposin'S Physiologic RoleNational Institute Of Neurological Disorders And Stroke2003–2007
  • Inborn Errors Of Sphingolipid CatabolismNational Institute Of Neurological Disorders And Stroke2000–2004
  • Prosaposins Physiologic RoleNational Institute Of Neurological Disorders And Stroke1997–2001
  • Enzyme Augmentation Therapy Of Gaucher DiseaseNational Center For Research Resources1995–2001
  • Clinical And Molecular Studies Of Gaucher DiseaseNational Center For Research Resources1995–2001
  • Gaucher DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases1996–2000
  • Inborn Errors Sphingolipid CatabolismNational Institute Of Neurological Disorders And Stroke1995–1998
  • Inborn Errors Of MetabolismNational Institute Of Diabetes And Digestive And Kidney Diseases1997
  • Gaucher Disease--A Prototype LipidosisNational Institute Of Diabetes And Digestive And Kidney Diseases1992–1995
  • Gaucher'S Disease--A Prototype LipidosisNational Institute Of Diabetes And Digestive And Kidney Diseases1994
  • Gaucher Disease--A Prototype LipidosisNational Institute Of Diabetes And Digestive And Kidney Diseases1992
  • Studies Of Gaucher Disease--A Prototype LipidosisNational Institute Of Diabetes And Digestive And Kidney Diseases1986–1991
  • Studies Of Gaucher Disease: A Prototype LipidosisNational Institute Of Diabetes And Digestive And Kidney Diseases1987–1990
  • Gaucher Disease--A Prototype LipidosisNational Institute Of Diabetes And Digestive And Kidney Diseases1986–1988
  • Gaucher Disease--A Prototype LipidosisNat Inst Of Arthritis, Diabetes, Digestive &Kidney Diseases1985

Hospital Affiliations

Dr. Gregory Grabowski, Dr. Gregory Grabowski, MD, Dr. G Grabowski, Dr. Gregory A Grabowski